CLPT
ClearPoint Neuro·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CLPT
Clearpoint Neuro, Inc.
A global therapy-enabling platform company providing navigation and delivery to the brain
Healthcare Equipment and Supplies
--
12/09/2019
NASDAQ Stock Exchange
115
12-31
Common stock
120 S. Sierra Ave., Suite 100, 92075, Solana Beach, California
--
ClearPoint Neuro, Inc., was incorporated in Delaware in 1998 as Surgi-Vision, Inc. On November 12, 2008, the company changed its name to SurgiVision, Inc., and on May 13, 2011, it changed its name to MRI Interventions, Inc. Mri Interventions, Inc., a medical device company focused on enabling physicians to see directly using intra-procedural magnetic resonance imaging (" MRI ") technology, Simultaneous development and commercialization of minimally invasive surgical techniques in the brain and heart.
Earnings Call
Company Financials
EPS
CLPT has released its 2025 Q3 earnings. EPS was reported at -0.21, versus the expected -0.2, missing expectations. The chart below visualizes how CLPT has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CLPT has released its 2025 Q3 earnings report, with revenue of 8.86M, reflecting a YoY change of 9.10%, and net profit of -5.89M, showing a YoY change of -18.44%. The Sankey diagram below clearly presents CLPT's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


